• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两代人携带低密度脂蛋白受体相关蛋白6独特突变呈现高骨量特征。

LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6.

作者信息

Whyte Michael P, Mumm Steven, Baker Jonathan C, Zhang Fan, Sedighi Homer, Duan Shenghui, Cundy Tim

机构信息

Division of Bone and Mineral Diseases, Department of Internal Medicine Washington University School of Medicine at Barnes-Jewish Hospital St. Louis MO USA.

Center for Metabolic Bone Disease and Molecular Research Shriners Hospitals for Children - St. Louis St. Louis MO USA.

出版信息

JBMR Plus. 2023 Mar 2;7(4):e10717. doi: 10.1002/jbm4.10717. eCollection 2023 Apr.

DOI:10.1002/jbm4.10717
PMID:37065631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10097642/
Abstract

Osteoblast Wnt/-catenin signaling conditions skeletal development and health. Bone formation is stimulated when on the osteoblast surface a Wnt binds to low-density lipoprotein receptor-related protein 5 (LRP5) or 6 (LRP6), in turn coupled to a frizzled receptor. Sclerostin and dickkopf1 inhibit osteogenesis if either links selectively to the first β-propeller of LRP5 or LRP6, thereby disassociating these cognate co-receptors from the frizzled receptor. Sixteen heterozygous mutations identified since 2002 within and three heterozygous mutations identified since 2019 within prevent this binding of sclerostin or dickkopf1 and account for the exceptionally rare, but highly instructive, autosomal dominant disorders called LRP5 and LRP6 high bone mass (HBM). Herein, we characterize LRP6 HBM in the first large affected family. Their novel heterozygous missense mutation (c.719C>T, p.Thr240Ile) was present in two middle-aged sisters and three of their sons. They considered themselves healthy. Their broad jaw and torus palatinus developed during childhood and, contrary to the two previous reports of LRP6 HBM, the appearance of their adult dentition was unremarkable. Skeletal modeling, defined radiographically, supported classification as an endosteal hyperostosis. Areal bone mineral density (g/cm) of the lumbar spine and total hip featured accelerated increases reaching -scores of ~ +8 and +6, respectively, although biochemical markers of bone formation were normal. © 2023 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

摘要

成骨细胞的Wnt/β-连环蛋白信号传导调控骨骼发育与健康。当Wnt在成骨细胞表面与低密度脂蛋白受体相关蛋白5(LRP5)或6(LRP6)结合时,会刺激骨形成,而LRP5或6又与卷曲受体相连。如果硬化蛋白或Dickkopf1选择性地与LRP5或LRP6的第一个β-螺旋桨结合,就会抑制骨生成,从而使这些同源共受体与卷曲受体解离。自2002年以来在LRP5中鉴定出16个杂合突变,自2019年以来在LRP6中鉴定出3个杂合突变,这些突变阻止了硬化蛋白或Dickkopf1的这种结合,导致了极为罕见但极具启发性的常染色体显性疾病,即LRP5和LRP6高骨量(HBM)疾病。在此,我们对首个大型患病家族中的LRP6 HBM进行了特征描述。他们的新型杂合LRP6错义突变(c.719C>T,p.Thr240Ile)存在于两名中年姐妹及其三个儿子中。他们自认为身体健康。她们宽阔的下颌和腭隆突在童年时期就已形成,与之前两份关于LRP6 HBM的报告不同,她们成年后的牙列外观并无异常。通过X线影像学定义的骨骼建模支持将其归类为骨内膜增生症。腰椎和全髋的骨面积密度(g/cm²)加速增加,Z值分别达到约+8和+6,尽管骨形成的生化指标正常。© 2023作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/0694f39ecd60/JBM4-7-e10717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/f5589b2cbd0b/JBM4-7-e10717-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/5dfe64ff0b70/JBM4-7-e10717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/66106d25b115/JBM4-7-e10717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/ea86ab3819de/JBM4-7-e10717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/44010aaadada/JBM4-7-e10717-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/b42bd48714bf/JBM4-7-e10717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/0694f39ecd60/JBM4-7-e10717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/f5589b2cbd0b/JBM4-7-e10717-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/5dfe64ff0b70/JBM4-7-e10717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/66106d25b115/JBM4-7-e10717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/ea86ab3819de/JBM4-7-e10717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/44010aaadada/JBM4-7-e10717-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/b42bd48714bf/JBM4-7-e10717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8f/10097642/0694f39ecd60/JBM4-7-e10717-g005.jpg

相似文献

1
LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6.两代人携带低密度脂蛋白受体相关蛋白6独特突变呈现高骨量特征。
JBMR Plus. 2023 Mar 2;7(4):e10717. doi: 10.1002/jbm4.10717. eCollection 2023 Apr.
2
New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.常染色体显性遗传性骨量增多症的新解释:载脂蛋白 E 受体相关蛋白 6 基因突变。
Bone. 2019 Oct;127:228-243. doi: 10.1016/j.bone.2019.05.003. Epub 2019 May 11.
3
High bone mass from mutation of low-density lipoprotein receptor-related protein 6 (LRP6).LRP6 基因突变导致的高骨量。
Bone. 2020 Dec;141:115550. doi: 10.1016/j.bone.2020.115550. Epub 2020 Jul 27.
4
Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.LRP4,一种新的 Dickkopf1 和 Sclerostin 受体,由成骨细胞表达,并在体内调节骨生长和代谢。
PLoS One. 2009 Nov 20;4(11):e7930. doi: 10.1371/journal.pone.0007930.
5
Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.通过改变WNT信号活性逆转LRP5依赖性骨质疏松症和SOST缺乏引起的硬化性骨疾病。
J Bone Miner Res. 2014 Jan;29(1):29-42. doi: 10.1002/jbmr.2059.
6
Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.骨密度配体硬化蛋白直接与低密度脂蛋白受体相关蛋白5(LRP5)相互作用,但不与LRP5G171V相互作用,以调节Wnt活性。
J Bone Miner Res. 2006 Nov;21(11):1738-49. doi: 10.1359/jbmr.060810.
7
Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).早发性骨质疏松症(EOOP)患者中 LRP5 和 LRP6 变异的临床表型和相关性。
J Bone Miner Res. 2021 Feb;36(2):271-282. doi: 10.1002/jbmr.4197. Epub 2020 Nov 12.
8
Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.Lrp5 和 Lrp6 在骨骼中的共缺失严重削弱了硬化蛋白抗体给药带来的骨量增加。
Bone. 2021 Feb;143:115708. doi: 10.1016/j.bone.2020.115708. Epub 2020 Oct 24.
9
Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.OPPG 和高骨量疾病的临床特征、治疗和随访:LRP5 是骨量的关键调节因子。
Osteoporos Int. 2024 Aug;35(8):1395-1406. doi: 10.1007/s00198-024-07080-x. Epub 2024 Apr 16.
10
Development of the Bone Phenotype and microRNA Profile in Adults With Low-Density Lipoprotein Receptor-Related Protein 5-High Bone Mass (LRP5-HBM) Disease.低密度脂蛋白受体相关蛋白5高骨量(LRP5-HBM)疾病成年患者的骨表型和微小RNA谱的发展
JBMR Plus. 2021 Sep 1;5(9):e10534. doi: 10.1002/jbm4.10534. eCollection 2021 Sep.

引用本文的文献

1
Evaluating the Anti-Osteoporotic Potential of Mediterranean Medicinal Plants: A Review of Current Evidence.评估地中海药用植物的抗骨质疏松潜力:当前证据综述
Pharmaceuticals (Basel). 2024 Oct 8;17(10):1341. doi: 10.3390/ph17101341.
2
Bone Material Properties in Bone Diseases Affecting Children.儿童骨骼疾病相关的骨材料特性。
Curr Osteoporos Rep. 2023 Dec;21(6):787-805. doi: 10.1007/s11914-023-00822-6. Epub 2023 Oct 28.
3
LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature.

本文引用的文献

1
High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench.高骨量疾病:从临床与基础研究的连接中获得新的认识。
J Bone Miner Res. 2023 Feb;38(2):229-247. doi: 10.1002/jbmr.4715. Epub 2022 Oct 21.
2
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.一个与低骨密度相关但与心血管事件无关的 LRP6 突变(Arg360His)存在于一个白人家族中。
Osteoporos Int. 2022 Nov;33(11):2445-2448. doi: 10.1007/s00198-022-06494-9. Epub 2022 Jul 15.
3
Mutations in LRP5 and BMP4 are associated with mesiodens, tooth agenesis, root malformation, and oral exostoses.
LRP5 高骨量(沃思型常染色体显性骨内膜骨肥厚症):病例报告及文献回顾。
Arch Osteoporos. 2023 Sep 2;18(1):112. doi: 10.1007/s11657-023-01319-6.
LRP5 和 BMP4 基因突变与中切牙、牙齿缺失、牙根畸形和口腔外生骨疣有关。
Clin Genet. 2022 Oct;102(4):333-338. doi: 10.1111/cge.14183. Epub 2022 Jul 2.
4
Utility of next-generation sequencing in genetic testing and counseling of disorders involving the musculoskeletal system-trends observed from a single genetic unit.下一代测序在涉及肌肉骨骼系统疾病的遗传检测和咨询中的应用——从单个遗传单位观察到的趋势。
J Orthop Surg Res. 2022 Feb 5;17(1):76. doi: 10.1186/s13018-022-02969-x.
5
LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence.Wnt信号通路中的LRP5和LRP6:相似性与差异
Front Cell Dev Biol. 2021 May 6;9:670960. doi: 10.3389/fcell.2021.670960. eCollection 2021.
6
The Genetic Architecture of High Bone Mass.高骨量的遗传结构。
Front Endocrinol (Lausanne). 2020 Oct 29;11:595653. doi: 10.3389/fendo.2020.595653. eCollection 2020.
7
A new LRP6 variant and Camurati-Engelmann-like disease.LRP6 新变体与卡姆鲁蒂-恩格尔曼样骨肥厚症。
Bone. 2021 Feb;143:115706. doi: 10.1016/j.bone.2020.115706. Epub 2020 Oct 22.
8
Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).早发性骨质疏松症(EOOP)患者中 LRP5 和 LRP6 变异的临床表型和相关性。
J Bone Miner Res. 2021 Feb;36(2):271-282. doi: 10.1002/jbmr.4197. Epub 2020 Nov 12.
9
Mechanically Driven Counter-Regulation of Cortical Bone Formation in Response to Sclerostin-Neutralizing Antibodies.机械驱动的成骨细胞对硬化蛋白中和抗体的反调节作用。
J Bone Miner Res. 2021 Feb;36(2):385-399. doi: 10.1002/jbmr.4193. Epub 2020 Nov 22.
10
High bone mass from mutation of low-density lipoprotein receptor-related protein 6 (LRP6).LRP6 基因突变导致的高骨量。
Bone. 2020 Dec;141:115550. doi: 10.1016/j.bone.2020.115550. Epub 2020 Jul 27.